Increased flux through the mevalonate pathway mediates fibrotic repair without injury.

Saved in:
Bibliographic Details
Title: Increased flux through the mevalonate pathway mediates fibrotic repair without injury.
Authors: Larson-Casey JL; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Vaid M; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Gu L; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., He C; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Cai GQ; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Ding Q; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Davis D; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Berryhill TF; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA., Wilson LS; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA., Barnes S; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA., Neighbors JD; Department of Medicine, and.; Department of Pharmacology, College of Medicine, Penn State University, Hershey, Pennsylvania, USA.; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Hohl RJ; Department of Medicine, and.; Department of Pharmacology, College of Medicine, Penn State University, Hershey, Pennsylvania, USA.; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Zimmerman KA; Department of Cell, Developmental, and Integrative Biology, and., Yoder BK; Department of Cell, Developmental, and Integrative Biology, and., Longhini ALF; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Hanumanthu VS; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Surolia R; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Antony VB; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Carter AB; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.; Birmingham Veterans Administration Medical Center, Birmingham, Alabama, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2019 Nov 01; Vol. 129 (11), pp. 4962-4978.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI127959